PAP39 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88009
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for PAP39 Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human PAP39. Peptide sequence: AVMELLIMAYALKTACARNIIGVIPYFPYSKQSKMRKRGSIVCKLLASML The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for PAP39 Antibody
![Western Blot: PAP39 Antibody [NBP2-88009]](https://resources.bio-techne.com/images/products/PAP39-Antibody-Western-Blot-NBP2-88009-img0001.jpg "Western Blot: PAP39 Antibody [NBP2-88009]")
Western Blot: PAP39 Antibody [NBP2-88009]
Western Blot: PAP39 Antibody [NBP2-88009] - Host: Rabbit. Target Name: PRPSAP1. Sample Tissue: Human Thymus Tumor lysates. Antibody Dilution: 1ug/mlApplications for PAP39 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: PAP39
Alternate Names
PAP3939 kDa phosphoribosypyrophosphate synthase-associated protein, phosphoribosyl pyrophosphate synthase-associated protein 1, phosphoribosyl pyrophosphate synthetase-associated protein 1, PRPP synthase-associated protein 1
Gene Symbol
PRPSAP1
Additional PAP39 Products
Product Specific Notices for PAP39 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...